Has Christopher Larsen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,664 in general payments to Christopher Larsen, MD across 29 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Larsen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Larsen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Larsen, MD

Hand Surgery · New York, NYNPI 1124550538

Payments from drug & device makers

$2,664in general payments, 2019–2025

Across 29 payments — averaging $91.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Suvon Surgical LLC$1K
Stryker$778
Acumed LLC$285
Axogen$174
Skeletal Dynamics Inc$106
Kerecis Limited$31
plus $90 from 3 others

What the payments were for

Food & beverage$1,46455%
Education$1,20045%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Suvon Surgical LLC	1	$1,200
Stryker	16	$778
Acumed LLC	4	$285
Axogen	3	$174
Skeletal Dynamics Inc	1	$106
Kerecis Limited	1	$31
Polaris Technology Solutions LLC	1	$30
EBI, LLC	1	$30
Highridge Medical LLC	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,664 in reported general payments places this provider in the 55th percentile of 178 hand surgery providers in New York.

See all hand surgery providers in New York →

Medicare billing

Part B allowed, 2024

$114,871

Medicare patients

196

Services billed

1,123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methylprednisolone	39	$225
Meloxicam	76	$85
Oxycodone Hcl	14	$51
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	13	$28
Tramadol Hcl	12	$10

Paid to pharmacies, not to this prescriber.

Other hand surgery in New York

Michael GottschalkNew York$1.7M
Michael HausmanNew York$549K
Nader PaksimaNew York$171K
Otis BarronNew York$122K
Duretti FufaNew York$95K
Dan ZlotolowNew York$91K
Jaehon KimNew York$60K
Daniel OseiNew York$51K
Jacques HacquebordNew York$46K
Anthony SapienzaNew York$44K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →